Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningiomaMasahiro Yamamoto, Chifumi Kitanaka, Tomomi Sanomachi et al.|Neuro-Oncology|2021Cited by 26
Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort studyMasayuki Kanamori, Yoshitaka Narita, Tomoo Matsutani et al.|Neuro-Oncology Advances|2024Cited by 3
Interim Analysis Data from Multi-Center Retrospective Observational Study of Effectiveness, Safety, and Treatment Status of Tirabrutinib in 161 Japanese Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma: Rosetta StudyMotoo Nagane, Kazuhiko Mishima, Manabu Natsumeda et al.|Blood|2024Cited by 1
ET-7 Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningiomaMasahiro Yamamoto, Chifumi Kitanaka, Hiroyuki Uchida et al.|Neuro-Oncology Advances|2021Cited by 0